Project Details
Description
A Phase III, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, Multicenter Study of the Safety and Efficacy of OT-101 (Atropine Sulfate 0.01%) in Treating the Progression of Myopia in Pediatric Subjects
Status | Active |
---|---|
Effective start/end date | 3/1/21 → 2/28/26 |
Funding
- OCUMENSION THERAPEUTICS LTD
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.